טוען...
Current approaches and advance in mantle cell lymphoma treatment
Mantle cell lymphoma (MCL) is a set of heterogeneous non-Hodgkin lymphoma characterized by involvement of lymph nodes, spleen, bone marrow and blood. Under conventional treatment, survival time is 4 to 5 years with short remission period and there is still no standard treatment for MCL. In general,...
שמור ב:
| הוצא לאור ב: | Stem Cell Investig |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AME Publishing Company
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4923656/ https://ncbi.nlm.nih.gov/pubmed/27358886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2306-9759.2015.09.02 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|